433 related articles for article (PubMed ID: 29298704)
21. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
[TBL] [Abstract][Full Text] [Related]
22. Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy.
Olivieri LJ; Kellman P; McCarter RJ; Cross RR; Hansen MS; Spurney CF
J Cardiovasc Magn Reson; 2016 Oct; 18(1):72. PubMed ID: 27788681
[TBL] [Abstract][Full Text] [Related]
23. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
[TBL] [Abstract][Full Text] [Related]
24. A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis.
Chamling B; Bietenbeck M; Drakos S; Korthals D; Vehof V; Stalling P; Meier C; Yilmaz A
Sci Rep; 2022 Dec; 12(1):21755. PubMed ID: 36526658
[TBL] [Abstract][Full Text] [Related]
25. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
26. T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
Kammerlander AA; Marzluf BA; Zotter-Tufaro C; Aschauer S; Duca F; Bachmann A; Knechtelsdorfer K; Wiesinger M; Pfaffenberger S; Greiser A; Lang IM; Bonderman D; Mascherbauer J
JACC Cardiovasc Imaging; 2016 Jan; 9(1):14-23. PubMed ID: 26684970
[TBL] [Abstract][Full Text] [Related]
27. T1 mapping and survival in systemic light-chain amyloidosis.
Banypersad SM; Fontana M; Maestrini V; Sado DM; Captur G; Petrie A; Piechnik SK; Whelan CJ; Herrey AS; Gillmore JD; Lachmann HJ; Wechalekar AD; Hawkins PN; Moon JC
Eur Heart J; 2015 Jan; 36(4):244-51. PubMed ID: 25411195
[TBL] [Abstract][Full Text] [Related]
28. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
[TBL] [Abstract][Full Text] [Related]
30. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients.
Chaikriangkrai K; Abbasi MA; Sarnari R; Dolan R; Lee D; Anderson AS; Ghafourian K; Khan SS; Vorovich EE; Rich JD; Wilcox JE; Blaisdell JA; Yancy CW; Carr J; Markl M
JACC Cardiovasc Imaging; 2020 Jul; 13(7):1521-1530. PubMed ID: 32199848
[TBL] [Abstract][Full Text] [Related]
32. Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis.
Gräni C; Bière L; Eichhorn C; Kaneko K; Agarwal V; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
Int J Cardiovasc Imaging; 2019 Jun; 35(6):1067-1078. PubMed ID: 30756221
[TBL] [Abstract][Full Text] [Related]
33. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
Karamitsos TD; Piechnik SK; Banypersad SM; Fontana M; Ntusi NB; Ferreira VM; Whelan CJ; Myerson SG; Robson MD; Hawkins PN; Neubauer S; Moon JC
JACC Cardiovasc Imaging; 2013 Apr; 6(4):488-97. PubMed ID: 23498672
[TBL] [Abstract][Full Text] [Related]
34. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
[TBL] [Abstract][Full Text] [Related]
35. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
[TBL] [Abstract][Full Text] [Related]
36. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
Boentert M; Florian A; Dräger B; Young P; Yilmaz A
J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis.
Miao F; Tang C; Ren G; Guo J; Zhao L; Xu W; Zhou X; Zhang L; Huang X
Front Oncol; 2023; 13():1069788. PubMed ID: 37207148
[TBL] [Abstract][Full Text] [Related]
38. Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.
Lehmonen L; Kaasalainen T; Atula S; Mustonen T; Holmström M
Int J Cardiovasc Imaging; 2019 Feb; 35(2):351-358. PubMed ID: 30848402
[TBL] [Abstract][Full Text] [Related]
39. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
[TBL] [Abstract][Full Text] [Related]
40. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
